Show simple item record

dc.contributor.authorBruno, Denise M
dc.contributor.authorWilson, Tracey E
dc.contributor.authorGany, Francesca
dc.contributor.authorAragones, Abraham
dc.date.accessioned2023-10-13T16:01:43Z
dc.date.available2023-10-13T16:01:43Z
dc.date.issued2014-06-02
dc.identifier.citationBruno DM, Wilson TE, Gany F, Aragones A. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine. 2014 Jul 16;32(33):4149-54. doi: 10.1016/j.vaccine.2014.05.058. Epub 2014 Jun 2. PMID: 24886959; PMCID: PMC4107630.en_US
dc.identifier.eissn1873-2518
dc.identifier.doi10.1016/j.vaccine.2014.05.058
dc.identifier.pmid24886959
dc.identifier.urihttp://hdl.handle.net/20.500.12648/13038
dc.description.abstractObjective: Minority populations in the United States are disproportionally affected by human papillomavirus (HPV) infection and HPV-related cancer. We sought to understand physician practices, knowledge and beliefs that affect utilization of the HPV vaccine in primary care settings serving large minority populations in areas with increased rates of HPV-related cancer.
dc.description.abstractStudy Design: Cross-sectional survey of randomly selected primary care providers, including pediatricians, family practice physicians and internists, serving large minority populations in Brooklyn, N.Y. and in areas with higher than average cervical cancer rates.
dc.description.abstractResults: Of 156 physicians randomly selected, 121 eligible providers responded to the survey; 64% were pediatricians, 19% were internists and 17% were family practitioners. Thirty-four percent of respondents reported that they routinely offered HPV vaccine to their eligible patients. Seventy percent of physicians reported that the lack of preventive care visits for patients in the eligible age group limited their ability to recommend the HPV vaccine and 70% of those who reported this barrier do not routinely recommend HPV vaccine. The lack of time to educate parents about the HPV vaccine and cost of the vaccine to their patients were two commonly reported barriers that affected whether providers offered the vaccine.
dc.description.abstractConclusions: Our study found that the majority of providers serving the highest risk populations for HPV infection and HPV-related cancers are not routinely recommending the HPV vaccine to their patients. Reasons for providers' failure to recommend the HPV vaccine routinely are identified and possible areas for targeted interventions to increase HPV vaccination rates are discussed.
dc.language.isoenen_US
dc.relation.urlhttps://www.sciencedirect.com/science/article/abs/pii/S0264410X14007348en_US
dc.rightsCopyright © 2014 Elsevier Ltd. All rights reserved.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHPV vaccine and primary care providersen_US
dc.subjectHPV vaccine barriersen_US
dc.subjectHuman papillomavirus vaccineen_US
dc.titleIdentifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations.en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleVaccineen_US
dc.source.volume32
dc.source.issue33
dc.source.beginpage4149
dc.source.endpage54
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryNetherlands
dc.description.versionAMen_US
refterms.dateFOA2023-10-13T16:01:45Z
html.description.abstractObjective: Minority populations in the United States are disproportionally affected by human papillomavirus (HPV) infection and HPV-related cancer. We sought to understand physician practices, knowledge and beliefs that affect utilization of the HPV vaccine in primary care settings serving large minority populations in areas with increased rates of HPV-related cancer.
html.description.abstractStudy Design: Cross-sectional survey of randomly selected primary care providers, including pediatricians, family practice physicians and internists, serving large minority populations in Brooklyn, N.Y. and in areas with higher than average cervical cancer rates.
html.description.abstractResults: Of 156 physicians randomly selected, 121 eligible providers responded to the survey; 64% were pediatricians, 19% were internists and 17% were family practitioners. Thirty-four percent of respondents reported that they routinely offered HPV vaccine to their eligible patients. Seventy percent of physicians reported that the lack of preventive care visits for patients in the eligible age group limited their ability to recommend the HPV vaccine and 70% of those who reported this barrier do not routinely recommend HPV vaccine. The lack of time to educate parents about the HPV vaccine and cost of the vaccine to their patients were two commonly reported barriers that affected whether providers offered the vaccine.
html.description.abstractConclusions: Our study found that the majority of providers serving the highest risk populations for HPV infection and HPV-related cancers are not routinely recommending the HPV vaccine to their patients. Reasons for providers' failure to recommend the HPV vaccine routinely are identified and possible areas for targeted interventions to increase HPV vaccination rates are discussed.
dc.description.institutionSUNY Downstateen_US
dc.description.departmentCommunity Health Sciencesen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalVaccine
dc.identifier.issue33en_US


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
nihms600972.pdf
Size:
223.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright © 2014 Elsevier Ltd. All rights reserved.
Except where otherwise noted, this item's license is described as Copyright © 2014 Elsevier Ltd. All rights reserved.